ZA972746B - Novel 2,3-benzodiazepine derivatives - Google Patents
Novel 2,3-benzodiazepine derivativesInfo
- Publication number
- ZA972746B ZA972746B ZA972746A ZA972746A ZA972746B ZA 972746 B ZA972746 B ZA 972746B ZA 972746 A ZA972746 A ZA 972746A ZA 972746 A ZA972746 A ZA 972746A ZA 972746 B ZA972746 B ZA 972746B
- Authority
- ZA
- South Africa
- Prior art keywords
- alkyl
- cycloalkyl
- benzodiazepine derivatives
- novel
- alkoxy
- Prior art date
Links
- RPBDCDQMCRHNLM-UHFFFAOYSA-N C1=NNC=C2C=CC=CC2=C1 Chemical class C1=NNC=C2C=CC=CC2=C1 RPBDCDQMCRHNLM-UHFFFAOYSA-N 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- PIEXCQIOSMOEOU-UHFFFAOYSA-N 1-bromo-3-chloro-5,5-dimethylimidazolidine-2,4-dione Chemical group CC1(C)N(Br)C(=O)N(Cl)C1=O PIEXCQIOSMOEOU-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/02—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Mono- or di-halo substituted 2,3-benzodiazepine derivatives of formula (I), their isomers and acid addition salts are new. R1, R2 = H, halogen, 1-4C alkyl, 1-4C alkoxy, nitro, CF3 or NR8R9; R3 = 1-4C alkyl, 3-5C cycloalkyl or COR13; R4, R5 = H or 1-3C alkyl; R6, R7 = H, Cl or Br, provided that not both are H at the same time; R8, R9 = H, 1-4C alkyl or COR10; R10, R13 = H, optionally substituted 1-6C alkyl, 6-10C aryl, 1-4C alkoxy, 3-5C cycloalkyl, 2-6C alkenyl, 3-5C cycloalkoxy or NR11R12; and R11, R12 = H, 1-4C alkyl, 3-5C cycloalkyl or 6-10C aryl.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9600871A HU9600871D0 (en) | 1996-04-04 | 1996-04-04 | New 2,3-benzodiazepine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA972746B true ZA972746B (en) | 1998-10-09 |
Family
ID=89993864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA972746A ZA972746B (en) | 1996-04-04 | 1997-04-01 | Novel 2,3-benzodiazepine derivatives |
Country Status (11)
| Country | Link |
|---|---|
| KR (1) | KR970069997A (en) |
| AT (1) | ATE254608T1 (en) |
| AU (1) | AU720745B2 (en) |
| BE (1) | BE1010962A4 (en) |
| DE (1) | DE59711013D1 (en) |
| ES (1) | ES2127699B1 (en) |
| IT (1) | IT1290453B1 (en) |
| NZ (1) | NZ314517A (en) |
| UA (1) | UA45358C2 (en) |
| YU (1) | YU13197A (en) |
| ZA (1) | ZA972746B (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU179018B (en) * | 1978-10-19 | 1982-08-28 | Gyogyszerkutato Intezet | Process for producing new 5h-2,3-benzodiazepine derivatives |
| HU186760B (en) * | 1981-03-12 | 1985-09-30 | Gyogyszerkutato Intezet | Process for preparing 3,4-dihydro-5h-2,3-aenzodiazepine derivatives |
| HU219778B (en) * | 1990-12-21 | 2001-07-30 | Gyógyszerkutató Intézet Közös Vállalat | Process for the preparation of N-acyl-2,3-benzodiazepines, their acid addition salts and pharmaceutical compositions containing them, and a group of compounds and pharmaceutical compositions containing them. |
| HU208429B (en) * | 1991-05-03 | 1993-10-28 | Gyogyszerkutato Intezet | Process for producing 1-/3-chloro-phenyl/-4-methyl-7,8-dimethoxy-5h-2,3-benzodiazepine of high purity |
| DE69525342T2 (en) * | 1994-08-31 | 2002-11-07 | Eli Lilly And Co., Indianapolis | Dihydro-2,3-benzodiazepine derivatives |
-
1997
- 1997-04-01 ZA ZA972746A patent/ZA972746B/en unknown
- 1997-04-03 BE BE9700308A patent/BE1010962A4/en not_active IP Right Cessation
- 1997-04-03 NZ NZ314517A patent/NZ314517A/en unknown
- 1997-04-03 UA UA97041584A patent/UA45358C2/en unknown
- 1997-04-03 KR KR1019970012301A patent/KR970069997A/en not_active Ceased
- 1997-04-03 YU YU13197A patent/YU13197A/en unknown
- 1997-04-04 AT AT97105591T patent/ATE254608T1/en not_active IP Right Cessation
- 1997-04-04 DE DE59711013T patent/DE59711013D1/en not_active Expired - Fee Related
- 1997-04-04 AU AU17734/97A patent/AU720745B2/en not_active Ceased
- 1997-04-04 ES ES009700703A patent/ES2127699B1/en not_active Expired - Fee Related
- 1997-04-04 IT IT000776 patent/IT1290453B1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| BE1010962A4 (en) | 1999-03-02 |
| UA45358C2 (en) | 2002-04-15 |
| AU1773497A (en) | 1997-10-09 |
| ATE254608T1 (en) | 2003-12-15 |
| ES2127699A1 (en) | 1999-04-16 |
| NZ314517A (en) | 2000-03-27 |
| ES2127699B1 (en) | 2000-01-16 |
| KR970069997A (en) | 1997-11-07 |
| IT1290453B1 (en) | 1998-12-03 |
| ITMI970776A1 (en) | 1998-10-04 |
| AU720745B2 (en) | 2000-06-08 |
| DE59711013D1 (en) | 2003-12-24 |
| YU13197A (en) | 1999-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE236129T1 (en) | DIHYDRO AND TETRAHYDROCINOLINE DERIVATIVES AS MEDICAL ANTIOXIDANTS | |
| PL334561A1 (en) | Novel phtalysinones | |
| MY131307A (en) | 1,5-benzodiazepine derivatives | |
| ZA945817B (en) | Tropyl 7-azaindol-3-ylcarboxyamides | |
| MXPA02012659A (en) | Chemical compounds. | |
| CY2472B1 (en) | Substituted dihydrobenzofurans as pde inhibitors. | |
| ATE180781T1 (en) | CRYSTALLINE TIAGABINE HYDROCHLORIDE MONOHYDRATE, ITS PREPARATION AND USE | |
| DE3682032D1 (en) | PROPYLAMINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS FUNGICIDES. | |
| HUP0001165A2 (en) | Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists, pharmaceutical compositions containing them and process for producing them | |
| MXPA02012470A (en) | Cyclic gmp-specific phosphodiesterase inhibitors. | |
| DE60005689D1 (en) | NEW AMINOBENZOPHENONE | |
| BG105539A (en) | Eletriptan hydrobromide monohydrate | |
| ATE164376T1 (en) | INDOLE DERIVATIVES AS STEROID 5 ALPHA-REDUCTASE INHIBITORS | |
| EP0204309A3 (en) | Substituted n-benzyl-4(benzhydryl) piperidines | |
| ZA972746B (en) | Novel 2,3-benzodiazepine derivatives | |
| BG106937A (en) | Novel indole derivatives | |
| BG105249A (en) | Fkbp inhibitors | |
| CA2423357A1 (en) | Fused heterocyclic derivatives as phosphodiesterase inhibitors | |
| HUP9700688A2 (en) | New 2,3-benzodiazepine derivatives and pharmaceutical compositions containing them | |
| ATE212634T1 (en) | METALLOPROTEASE INHIBITORS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME | |
| ES8401066A1 (en) | 1,5-substituted isoquinoline derivatives. | |
| ZA942970B (en) | Pyrido(1,2,3-de)quinoxaline derivatives, process for their production and their use in pharmaceutical agents. | |
| TW282458B (en) | ||
| WO2000008005A3 (en) | Piperazinone derivatives | |
| IL126548A0 (en) | Use of aspirochlorine or derivatives thereof as immunosuppressive agents |